Supplementary Results Deep sequencing analyses of on ... · Supplementary Results . Deep sequencing...
Transcript of Supplementary Results Deep sequencing analyses of on ... · Supplementary Results . Deep sequencing...
Supplementary Results
Deep sequencing analyses of on-target cleavages at a clonal level
In order to analyse the indel patterns at the on-target site and examine the timing of the cleavages
we carried out deep sequencing analyses of all 20 colonies shown in Figure 1e Out of the twenty
colonies analysed seventeen showed consistent results with the flow cytometry data (Fig 1e)
nearly 100 of reads at the target site of these colonies contain indels (Supplementary Table 1) The
discrepancy between the two sets of data for the remaining three colonies (Cas95-3 8-3 and 8-9)
can be explained by the presence of GPI-positive wild-type cells in each of the three colonies
Expansion of these cells can occur between FACS analysis and DNA extraction as shown in a
competition assay between wild type and Piga-deficient cells (Supplementary Fig 6) and will
directly result in higher number of reads derived from the wild-type sequence It is also evident from
the indel patterns shown in Supplementary Figure 5 that eighteen of the twenty colonies analysed
contain single clonal indels Since the Piga gene is X-linked this indicates that the cleavage event
occurred in the clonal origin of each colony In particular the Cas95-7 clone has a clonal 6-bp in-
frame deletion (Supplementary Fig 5) which explains the low percentage of FLAER-negative cells
observed in Figure 1e The remaining two colonies Cas98-3 and Cas98-9 carried multiple
deletions (Supplementary Fig 5) indicating that the on-target cleavage occurred at a later stage
during colony expansion
Deep sequencing analyses of off-target cleavages in cell lines constitutively expressing both Cas9
and gRNA
In addition we analysed the frequency of off-target cleavages at 275 potential off-target sites Out
of these 95 sites have up to 5 mismatches between the genome and the Piga Site 2 gRNA and are
followed by the NGG PAM Another 95 sites have up to 5 mismatches but these contain the NAG
PAM rather than the NGG PAM The remaining 85 sites have mismatches and bulges between the
sites and the gRNA and are followed by either the NGG or the NAG PAMs (Supplementary Table 1
2)
Out of the 275 potential off-target sites analysed we identified only 2 loci (l20_5tm-2 and l20_5tm-
21) that were cleaved albeit at different frequencies (Supplementary Table 1 2) Site l20_5tm-21
which contains 3 mismatches was targeted by the gRNA as efficiently as the on-target site
(Supplementary Fig 7) However site l20_5tm-2 with 2 mismatches displayed different cleavage
frequencies in each of the twenty colonies analysed (Supplementary Table 1) Since these cell lines
constitutively express both Cas9 and the gRNA cleavages have occurred at various time points
during cell expansion which explains the various cutting frequencies and indel patterns
(Supplementary Fig 8) It is thus evident that site l20_5tm-2 represents a weak off-target site in
comparison to a strong off-target site like site l20_5tm-21 Importantly we examined 19 potential
off-target sites in protein-coding regions (CCDS) and found that none showed any off-target
cleavages (Supplementary Table 1 2) Thus far all published off-target cleavage analyses have been
performed using transiently transfected samples 1-4 To compare off-target cleavages between
transient and constitutive expression of the CRISPR-Cas system we analysed Cas9-expressing ESCs
transiently transfected with the Piga Site 2 gRNA expression vector by deep sequencing The same 2
off-target sites which were identified in the clones constitutively expressing Cas9 and the gRNA
Nature Biotechnology doi101038nbt2800
were also the only 2 identified in the transiently transfected cells (Supplementary Table 1 2)
Interestingly Site 2 of the Piga gene and the off-target site l20_5tm-21 displayed similar cleavage
frequencies whereas the weak off-target site l20_5tm-2 displayed lower cutting frequency
Taken together our results indicate that the CRISPR-Cas system does introduce DSBs at selected off-
target sites It is therefore important to carefully design gRNAs that are expected to have minimum
deleterious consequences such as exonic off-targets
Reference
1 Fu Y et al High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells Nature biotechnology 31 822-826 (2013)
2 Hsu PD et al DNA targeting specificity of RNA-guided Cas9 nucleases Nature biotechnology 31 827-832 (2013)
3 Mali P et al CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering Nature biotechnology 31 833-838 (2013)
4 Pattanayak V et al High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity Nature biotechnology 31 839-843 (2013)
Nature Biotechnology doi101038nbt2800
Supplementary Figure 1 Genes involved in the GPI biosynthesis pathway and 6TG genotoxicity a Sche-matic of GPI biosynthesis The first and second reactions occur at the cytoplasmic side of the ER but subse-quent reactions occur at the luminal side of the ER GPI-anchored proteins are transported to the cell surface via the Golgi apparatus Pgap2 is involved in fatty acid remodelling in the Golgi Aerolysin from Aeromonas hydrophila and alpha-toxin from Clostridium septicum are cytolytic pore-forming toxins and use GPI-anchored proteins as their receptors GPI-anchored proteins are essential for development as Piga knockout mice are embryonic lethal however GPI-deficient cells are viable b Schematic of 6TG metabolism and its genotoxicity Hprt converts 6TG into thio-GMP After further modification thio-dGTP is formed and incorporated into genomic DNA during replication resulting in DNA mispairing Mismatch repair (MMR) genes recognise the mispairing and induce apoptosis In contrast MMR-deficient cells are not able to recog-nise the mispairing and are therefore able to survive under 6TG treatment Hprt-deficient cells are also viable in the presence of 6TG since 6TG cannot be converted into a toxic molecule
AcPigaPigcPigpPigqPIgyDpm2
Dpm1Dpm2Dpm3
Mpdu1
Pigl
Pigw
PigmPigx Pigf
PigoPigfPigg
Gpaa1PigkPigsPigtPigu Pgap2Pigv Pign Pigb
Protein
Transport to cell surfaceER lumen
Cytoplasm
a
Hprt
Mlh1Msh2Msh6Pms2
N
NSH
NHH2N
N
N
NSH
NH2N
N
6-Thioguanine (6TG)
Thio-GMP Thio-dGTP
OP
N
NSH
NH2N
N
OPPP
Incorporate into genomic DNA
MMR(+) Apoptosis
MMR(-) Survive
b
Phosphatidylinositol
Dolichol phosphate
Glucosamine
Mannose
Phosphoethanolamine
Nature Biotechnology doi101038nbt2800
a bPB PBbpAEF1α Puro-2A-hCas9
HindIII
19 kb
clone 4clone 5
clone 8clone 9
clone 10clone 11
clone 12clone 3
30
506080100
20
15
10
05
Supplementary Figure 2 Generation of mouse ESC lines expressing hCas9 by single-copy piggyBac-mediated transgenesis a Schematic of the piggyBac transposon vector carrying human elongation factor 1a (EF1a)-driven hCas9 fused with the puromycin resistant gene via self-cleavage peptide T2A PB piggyBac repeats bpA bovine growth hormone polyadenylation signal sequence The thick line represents the probe for Southern blot analysis b Southern blot analysis of hCas9-expressing ESC lines Genomic DNA was digested with HindIII and hybridized with the radiolabeled probe shown in a All clones carry a single piggyBac transpo-son Note that the shortest band size is 19kb Size markers are indicated on the right
kb
Nature Biotechnology doi101038nbt2800
Site4Site2
Site3 Site1
Site 1 TCACTCCAGACCCATTTAGG AGGSite 2 GAAGAGAGCATCATGGGCCA TGGSite 3 CGGATTTGCTGATGTCAGCT CGGSite 4 CAGAGAAAGAACTGTGGGAA TGG
Piga
U6 gRNA scaffold Terminatorspacer
GGACGAAACACCGGGTCTTCGAGAAGACGTTTTAGAGCTAGACCTGCTTTGTGGCCCAGAAGCTCTTCTGCAAAATCTCGATCT
Transciption
5rsquo-CACC NNNNN NNNNN NNNNN NNNNN GT-3rsquo 3rsquo-nnnnn nnnnn nnnnn nnnnn CAAAAT-5rsquo
Duplex oligos
a
d
b
FLA
ER
-neg
ativ
e ce
lls (
)
FSC
FLA
ER
cSite 2
Site 3 No gRNA
Site 1
Supplementary Figure 3 Construction and validation of gRNA-expression vector a Schematic of the gRNA cloning vector BbsI digestion removes the spacer and produces cohesive ends which allows duplex oligonu-cleotides with compatible overhangs to ligate into Underlined BbsI sites For the duplex oligonucleotides compatible overhangs are shown in blue gRNA sequences are shown as N (top strand) and n (bottom strand) b The sequences and the genomic positions of gRNAs targeting the Piga gene The genomic PAM sequence of each gRNA is shown in red c Flow cytometry analysis of GPI-anchored protein expression Analysis was performed 6 days post transfection d A summary of the flow cytometry analyses in c Transfec-tion was performed in triplicates Data are shown as mean plusmn sd (n=3)
Site 4
0
5
10
15
20
Site 1 Site 2 Site 3 Site 4 No gRNA
Nature Biotechnology doi101038nbt2800
a bU6 20-bp
guide seqgRNA scaffold T7PB PBPGKneopA
MscI
12 kb
30
506080100
20
15
10
05
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
JM8-Cas5 JM8-Cas8
Supplementary Figure 4 Generation of doubly transgenic ESC lines a Schematic of the piggyBac transpo-son vector carrying the gRNA expression cassette together with the G418 resistant gene cassette The thick line represents the probe for Southern blot analysis b Southern blot analysis of gRNA-expressing ESC clones Genomic DNA was digested with MscI and hybridized with the radiolabeled probe shown in a Note that the shortest band size is 12kb All clones analysed carry a single gRNA expression cassette
kb
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
were also the only 2 identified in the transiently transfected cells (Supplementary Table 1 2)
Interestingly Site 2 of the Piga gene and the off-target site l20_5tm-21 displayed similar cleavage
frequencies whereas the weak off-target site l20_5tm-2 displayed lower cutting frequency
Taken together our results indicate that the CRISPR-Cas system does introduce DSBs at selected off-
target sites It is therefore important to carefully design gRNAs that are expected to have minimum
deleterious consequences such as exonic off-targets
Reference
1 Fu Y et al High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells Nature biotechnology 31 822-826 (2013)
2 Hsu PD et al DNA targeting specificity of RNA-guided Cas9 nucleases Nature biotechnology 31 827-832 (2013)
3 Mali P et al CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering Nature biotechnology 31 833-838 (2013)
4 Pattanayak V et al High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity Nature biotechnology 31 839-843 (2013)
Nature Biotechnology doi101038nbt2800
Supplementary Figure 1 Genes involved in the GPI biosynthesis pathway and 6TG genotoxicity a Sche-matic of GPI biosynthesis The first and second reactions occur at the cytoplasmic side of the ER but subse-quent reactions occur at the luminal side of the ER GPI-anchored proteins are transported to the cell surface via the Golgi apparatus Pgap2 is involved in fatty acid remodelling in the Golgi Aerolysin from Aeromonas hydrophila and alpha-toxin from Clostridium septicum are cytolytic pore-forming toxins and use GPI-anchored proteins as their receptors GPI-anchored proteins are essential for development as Piga knockout mice are embryonic lethal however GPI-deficient cells are viable b Schematic of 6TG metabolism and its genotoxicity Hprt converts 6TG into thio-GMP After further modification thio-dGTP is formed and incorporated into genomic DNA during replication resulting in DNA mispairing Mismatch repair (MMR) genes recognise the mispairing and induce apoptosis In contrast MMR-deficient cells are not able to recog-nise the mispairing and are therefore able to survive under 6TG treatment Hprt-deficient cells are also viable in the presence of 6TG since 6TG cannot be converted into a toxic molecule
AcPigaPigcPigpPigqPIgyDpm2
Dpm1Dpm2Dpm3
Mpdu1
Pigl
Pigw
PigmPigx Pigf
PigoPigfPigg
Gpaa1PigkPigsPigtPigu Pgap2Pigv Pign Pigb
Protein
Transport to cell surfaceER lumen
Cytoplasm
a
Hprt
Mlh1Msh2Msh6Pms2
N
NSH
NHH2N
N
N
NSH
NH2N
N
6-Thioguanine (6TG)
Thio-GMP Thio-dGTP
OP
N
NSH
NH2N
N
OPPP
Incorporate into genomic DNA
MMR(+) Apoptosis
MMR(-) Survive
b
Phosphatidylinositol
Dolichol phosphate
Glucosamine
Mannose
Phosphoethanolamine
Nature Biotechnology doi101038nbt2800
a bPB PBbpAEF1α Puro-2A-hCas9
HindIII
19 kb
clone 4clone 5
clone 8clone 9
clone 10clone 11
clone 12clone 3
30
506080100
20
15
10
05
Supplementary Figure 2 Generation of mouse ESC lines expressing hCas9 by single-copy piggyBac-mediated transgenesis a Schematic of the piggyBac transposon vector carrying human elongation factor 1a (EF1a)-driven hCas9 fused with the puromycin resistant gene via self-cleavage peptide T2A PB piggyBac repeats bpA bovine growth hormone polyadenylation signal sequence The thick line represents the probe for Southern blot analysis b Southern blot analysis of hCas9-expressing ESC lines Genomic DNA was digested with HindIII and hybridized with the radiolabeled probe shown in a All clones carry a single piggyBac transpo-son Note that the shortest band size is 19kb Size markers are indicated on the right
kb
Nature Biotechnology doi101038nbt2800
Site4Site2
Site3 Site1
Site 1 TCACTCCAGACCCATTTAGG AGGSite 2 GAAGAGAGCATCATGGGCCA TGGSite 3 CGGATTTGCTGATGTCAGCT CGGSite 4 CAGAGAAAGAACTGTGGGAA TGG
Piga
U6 gRNA scaffold Terminatorspacer
GGACGAAACACCGGGTCTTCGAGAAGACGTTTTAGAGCTAGACCTGCTTTGTGGCCCAGAAGCTCTTCTGCAAAATCTCGATCT
Transciption
5rsquo-CACC NNNNN NNNNN NNNNN NNNNN GT-3rsquo 3rsquo-nnnnn nnnnn nnnnn nnnnn CAAAAT-5rsquo
Duplex oligos
a
d
b
FLA
ER
-neg
ativ
e ce
lls (
)
FSC
FLA
ER
cSite 2
Site 3 No gRNA
Site 1
Supplementary Figure 3 Construction and validation of gRNA-expression vector a Schematic of the gRNA cloning vector BbsI digestion removes the spacer and produces cohesive ends which allows duplex oligonu-cleotides with compatible overhangs to ligate into Underlined BbsI sites For the duplex oligonucleotides compatible overhangs are shown in blue gRNA sequences are shown as N (top strand) and n (bottom strand) b The sequences and the genomic positions of gRNAs targeting the Piga gene The genomic PAM sequence of each gRNA is shown in red c Flow cytometry analysis of GPI-anchored protein expression Analysis was performed 6 days post transfection d A summary of the flow cytometry analyses in c Transfec-tion was performed in triplicates Data are shown as mean plusmn sd (n=3)
Site 4
0
5
10
15
20
Site 1 Site 2 Site 3 Site 4 No gRNA
Nature Biotechnology doi101038nbt2800
a bU6 20-bp
guide seqgRNA scaffold T7PB PBPGKneopA
MscI
12 kb
30
506080100
20
15
10
05
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
JM8-Cas5 JM8-Cas8
Supplementary Figure 4 Generation of doubly transgenic ESC lines a Schematic of the piggyBac transpo-son vector carrying the gRNA expression cassette together with the G418 resistant gene cassette The thick line represents the probe for Southern blot analysis b Southern blot analysis of gRNA-expressing ESC clones Genomic DNA was digested with MscI and hybridized with the radiolabeled probe shown in a Note that the shortest band size is 12kb All clones analysed carry a single gRNA expression cassette
kb
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Figure 1 Genes involved in the GPI biosynthesis pathway and 6TG genotoxicity a Sche-matic of GPI biosynthesis The first and second reactions occur at the cytoplasmic side of the ER but subse-quent reactions occur at the luminal side of the ER GPI-anchored proteins are transported to the cell surface via the Golgi apparatus Pgap2 is involved in fatty acid remodelling in the Golgi Aerolysin from Aeromonas hydrophila and alpha-toxin from Clostridium septicum are cytolytic pore-forming toxins and use GPI-anchored proteins as their receptors GPI-anchored proteins are essential for development as Piga knockout mice are embryonic lethal however GPI-deficient cells are viable b Schematic of 6TG metabolism and its genotoxicity Hprt converts 6TG into thio-GMP After further modification thio-dGTP is formed and incorporated into genomic DNA during replication resulting in DNA mispairing Mismatch repair (MMR) genes recognise the mispairing and induce apoptosis In contrast MMR-deficient cells are not able to recog-nise the mispairing and are therefore able to survive under 6TG treatment Hprt-deficient cells are also viable in the presence of 6TG since 6TG cannot be converted into a toxic molecule
AcPigaPigcPigpPigqPIgyDpm2
Dpm1Dpm2Dpm3
Mpdu1
Pigl
Pigw
PigmPigx Pigf
PigoPigfPigg
Gpaa1PigkPigsPigtPigu Pgap2Pigv Pign Pigb
Protein
Transport to cell surfaceER lumen
Cytoplasm
a
Hprt
Mlh1Msh2Msh6Pms2
N
NSH
NHH2N
N
N
NSH
NH2N
N
6-Thioguanine (6TG)
Thio-GMP Thio-dGTP
OP
N
NSH
NH2N
N
OPPP
Incorporate into genomic DNA
MMR(+) Apoptosis
MMR(-) Survive
b
Phosphatidylinositol
Dolichol phosphate
Glucosamine
Mannose
Phosphoethanolamine
Nature Biotechnology doi101038nbt2800
a bPB PBbpAEF1α Puro-2A-hCas9
HindIII
19 kb
clone 4clone 5
clone 8clone 9
clone 10clone 11
clone 12clone 3
30
506080100
20
15
10
05
Supplementary Figure 2 Generation of mouse ESC lines expressing hCas9 by single-copy piggyBac-mediated transgenesis a Schematic of the piggyBac transposon vector carrying human elongation factor 1a (EF1a)-driven hCas9 fused with the puromycin resistant gene via self-cleavage peptide T2A PB piggyBac repeats bpA bovine growth hormone polyadenylation signal sequence The thick line represents the probe for Southern blot analysis b Southern blot analysis of hCas9-expressing ESC lines Genomic DNA was digested with HindIII and hybridized with the radiolabeled probe shown in a All clones carry a single piggyBac transpo-son Note that the shortest band size is 19kb Size markers are indicated on the right
kb
Nature Biotechnology doi101038nbt2800
Site4Site2
Site3 Site1
Site 1 TCACTCCAGACCCATTTAGG AGGSite 2 GAAGAGAGCATCATGGGCCA TGGSite 3 CGGATTTGCTGATGTCAGCT CGGSite 4 CAGAGAAAGAACTGTGGGAA TGG
Piga
U6 gRNA scaffold Terminatorspacer
GGACGAAACACCGGGTCTTCGAGAAGACGTTTTAGAGCTAGACCTGCTTTGTGGCCCAGAAGCTCTTCTGCAAAATCTCGATCT
Transciption
5rsquo-CACC NNNNN NNNNN NNNNN NNNNN GT-3rsquo 3rsquo-nnnnn nnnnn nnnnn nnnnn CAAAAT-5rsquo
Duplex oligos
a
d
b
FLA
ER
-neg
ativ
e ce
lls (
)
FSC
FLA
ER
cSite 2
Site 3 No gRNA
Site 1
Supplementary Figure 3 Construction and validation of gRNA-expression vector a Schematic of the gRNA cloning vector BbsI digestion removes the spacer and produces cohesive ends which allows duplex oligonu-cleotides with compatible overhangs to ligate into Underlined BbsI sites For the duplex oligonucleotides compatible overhangs are shown in blue gRNA sequences are shown as N (top strand) and n (bottom strand) b The sequences and the genomic positions of gRNAs targeting the Piga gene The genomic PAM sequence of each gRNA is shown in red c Flow cytometry analysis of GPI-anchored protein expression Analysis was performed 6 days post transfection d A summary of the flow cytometry analyses in c Transfec-tion was performed in triplicates Data are shown as mean plusmn sd (n=3)
Site 4
0
5
10
15
20
Site 1 Site 2 Site 3 Site 4 No gRNA
Nature Biotechnology doi101038nbt2800
a bU6 20-bp
guide seqgRNA scaffold T7PB PBPGKneopA
MscI
12 kb
30
506080100
20
15
10
05
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
JM8-Cas5 JM8-Cas8
Supplementary Figure 4 Generation of doubly transgenic ESC lines a Schematic of the piggyBac transpo-son vector carrying the gRNA expression cassette together with the G418 resistant gene cassette The thick line represents the probe for Southern blot analysis b Southern blot analysis of gRNA-expressing ESC clones Genomic DNA was digested with MscI and hybridized with the radiolabeled probe shown in a Note that the shortest band size is 12kb All clones analysed carry a single gRNA expression cassette
kb
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
a bPB PBbpAEF1α Puro-2A-hCas9
HindIII
19 kb
clone 4clone 5
clone 8clone 9
clone 10clone 11
clone 12clone 3
30
506080100
20
15
10
05
Supplementary Figure 2 Generation of mouse ESC lines expressing hCas9 by single-copy piggyBac-mediated transgenesis a Schematic of the piggyBac transposon vector carrying human elongation factor 1a (EF1a)-driven hCas9 fused with the puromycin resistant gene via self-cleavage peptide T2A PB piggyBac repeats bpA bovine growth hormone polyadenylation signal sequence The thick line represents the probe for Southern blot analysis b Southern blot analysis of hCas9-expressing ESC lines Genomic DNA was digested with HindIII and hybridized with the radiolabeled probe shown in a All clones carry a single piggyBac transpo-son Note that the shortest band size is 19kb Size markers are indicated on the right
kb
Nature Biotechnology doi101038nbt2800
Site4Site2
Site3 Site1
Site 1 TCACTCCAGACCCATTTAGG AGGSite 2 GAAGAGAGCATCATGGGCCA TGGSite 3 CGGATTTGCTGATGTCAGCT CGGSite 4 CAGAGAAAGAACTGTGGGAA TGG
Piga
U6 gRNA scaffold Terminatorspacer
GGACGAAACACCGGGTCTTCGAGAAGACGTTTTAGAGCTAGACCTGCTTTGTGGCCCAGAAGCTCTTCTGCAAAATCTCGATCT
Transciption
5rsquo-CACC NNNNN NNNNN NNNNN NNNNN GT-3rsquo 3rsquo-nnnnn nnnnn nnnnn nnnnn CAAAAT-5rsquo
Duplex oligos
a
d
b
FLA
ER
-neg
ativ
e ce
lls (
)
FSC
FLA
ER
cSite 2
Site 3 No gRNA
Site 1
Supplementary Figure 3 Construction and validation of gRNA-expression vector a Schematic of the gRNA cloning vector BbsI digestion removes the spacer and produces cohesive ends which allows duplex oligonu-cleotides with compatible overhangs to ligate into Underlined BbsI sites For the duplex oligonucleotides compatible overhangs are shown in blue gRNA sequences are shown as N (top strand) and n (bottom strand) b The sequences and the genomic positions of gRNAs targeting the Piga gene The genomic PAM sequence of each gRNA is shown in red c Flow cytometry analysis of GPI-anchored protein expression Analysis was performed 6 days post transfection d A summary of the flow cytometry analyses in c Transfec-tion was performed in triplicates Data are shown as mean plusmn sd (n=3)
Site 4
0
5
10
15
20
Site 1 Site 2 Site 3 Site 4 No gRNA
Nature Biotechnology doi101038nbt2800
a bU6 20-bp
guide seqgRNA scaffold T7PB PBPGKneopA
MscI
12 kb
30
506080100
20
15
10
05
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
JM8-Cas5 JM8-Cas8
Supplementary Figure 4 Generation of doubly transgenic ESC lines a Schematic of the piggyBac transpo-son vector carrying the gRNA expression cassette together with the G418 resistant gene cassette The thick line represents the probe for Southern blot analysis b Southern blot analysis of gRNA-expressing ESC clones Genomic DNA was digested with MscI and hybridized with the radiolabeled probe shown in a Note that the shortest band size is 12kb All clones analysed carry a single gRNA expression cassette
kb
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Site4Site2
Site3 Site1
Site 1 TCACTCCAGACCCATTTAGG AGGSite 2 GAAGAGAGCATCATGGGCCA TGGSite 3 CGGATTTGCTGATGTCAGCT CGGSite 4 CAGAGAAAGAACTGTGGGAA TGG
Piga
U6 gRNA scaffold Terminatorspacer
GGACGAAACACCGGGTCTTCGAGAAGACGTTTTAGAGCTAGACCTGCTTTGTGGCCCAGAAGCTCTTCTGCAAAATCTCGATCT
Transciption
5rsquo-CACC NNNNN NNNNN NNNNN NNNNN GT-3rsquo 3rsquo-nnnnn nnnnn nnnnn nnnnn CAAAAT-5rsquo
Duplex oligos
a
d
b
FLA
ER
-neg
ativ
e ce
lls (
)
FSC
FLA
ER
cSite 2
Site 3 No gRNA
Site 1
Supplementary Figure 3 Construction and validation of gRNA-expression vector a Schematic of the gRNA cloning vector BbsI digestion removes the spacer and produces cohesive ends which allows duplex oligonu-cleotides with compatible overhangs to ligate into Underlined BbsI sites For the duplex oligonucleotides compatible overhangs are shown in blue gRNA sequences are shown as N (top strand) and n (bottom strand) b The sequences and the genomic positions of gRNAs targeting the Piga gene The genomic PAM sequence of each gRNA is shown in red c Flow cytometry analysis of GPI-anchored protein expression Analysis was performed 6 days post transfection d A summary of the flow cytometry analyses in c Transfec-tion was performed in triplicates Data are shown as mean plusmn sd (n=3)
Site 4
0
5
10
15
20
Site 1 Site 2 Site 3 Site 4 No gRNA
Nature Biotechnology doi101038nbt2800
a bU6 20-bp
guide seqgRNA scaffold T7PB PBPGKneopA
MscI
12 kb
30
506080100
20
15
10
05
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
JM8-Cas5 JM8-Cas8
Supplementary Figure 4 Generation of doubly transgenic ESC lines a Schematic of the piggyBac transpo-son vector carrying the gRNA expression cassette together with the G418 resistant gene cassette The thick line represents the probe for Southern blot analysis b Southern blot analysis of gRNA-expressing ESC clones Genomic DNA was digested with MscI and hybridized with the radiolabeled probe shown in a Note that the shortest band size is 12kb All clones analysed carry a single gRNA expression cassette
kb
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
a bU6 20-bp
guide seqgRNA scaffold T7PB PBPGKneopA
MscI
12 kb
30
506080100
20
15
10
05
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 10
JM8-Cas5 JM8-Cas8
Supplementary Figure 4 Generation of doubly transgenic ESC lines a Schematic of the piggyBac transpo-son vector carrying the gRNA expression cassette together with the G418 resistant gene cassette The thick line represents the probe for Southern blot analysis b Southern blot analysis of gRNA-expressing ESC clones Genomic DNA was digested with MscI and hybridized with the radiolabeled probe shown in a Note that the shortest band size is 12kb All clones analysed carry a single gRNA expression cassette
kb
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
JM8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
100
200
300
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
2000
2500
3000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
5000
10000
15000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
-30
-118-33
Cou
nts
Indel size [bp]
Supplementary Figure 5 Size distribution of indels at the on-target site of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions When deletions are smaller than 20 bp the actual deletion sizes are indicated Note that Cas98-4 has a 118-bp deletion Its read count is much lower than the rest because the corresponding small PCR products were depleted during size selection
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Figure 6 A competition assay between wild type and Piga-deficient ESCs ab Flow cytom-etry analyses Piga-deficient ESCs were obtained by alpha-toxin selection of hCas9-expressing ESCs trans-fected with the Piga Site 2 gRNA expression vector Wild type and mutant ESCs were mix at a 11 ratio and cultured under feeder-free conditions in 4 replicates Flow cytometry analyses using FLAER were performed at every passage The Piga-deficient (FLAER-negative) ESC population was depleted over time Data are shown as mean plusmn sd (n=4)
a P1 P2 P3 P4 P5 P6
b
0
10
20
30
40
50
60
70
P1 P2 P3 P4 P5 P6
FLA
ER
-neg
ativ
e (
)
Passage
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
JM8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
1000
2000
3000
4000
5000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 7 Size distribution of indels at the off-target site (l20_5tm-21) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
JM8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus1
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus6
0
500
1000
4400
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus8
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas95minus10
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus1
0
500
1000
2800
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus2
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus3
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus4
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus5
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus6
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus7
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus8
0
500
1000
7000
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus9
0
500
1000
1500
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cas98minus10
0
500
1000
6100
leminus20
minus15
minus10 minus5 0 5 10 15
ge20
Cou
nts
Indel size [bp]
Supplementary Figure 8 Size distribution of indels at the off-target site (l20_5tm-2) of the gRNA targeting Piga Site 2 Plus values and blue bars represent insertions while minus values and red bars represent deletions
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Figure 9 Proviral silencing BFP-positve fractions were measured at 2 and 8 days post infection Data shown is from one of the duplicated experiments Similar silencing was observed in the duplicated experiment Paired t-test was performed
0
20
40
60
80
100
2 8Days post infection
p=00003
Piga Site 3 endogenousPiga Site 1 endogenousPiga Site 2 endogenousPiga Site 3 alteredPiga Site 1 alteredEmpty vectorMock infection
BFP
-pos
itive
()
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Dpm1 (1)
Pgap2 (2)
Pigg (1)
Pign (1)
Pigt (1)
Pigy (1)
Dpm2 (1)
Piga (2)
Pigh (1)
Pigo (1)
Pigu (1)
Control
Dpm3 (1)
Pigb (1)
Pigk (1)
Pigp (1)
Pigv (2)
Gpaa1 (1)
Pigc (2)
Pigl (2)
Pigq (1)
Pigw (2)
Mpdu1 (1)
Pigf (2)
Pigm (2)
Pigs (1)
Pigx (2)
Supplementary Figure 10 Flow cytometry analysis of ESCs transfected with the indicated gRNA expression vectors These are the flow cytometry profiles that are summarised in Figure 3b The profiles from the gRNAs with higher FLAER-negative values are shown for each of the 26 GPI pathway genes Note that Pigf Pign Pigq and Pigw knockouts do not completely lose the expression of GPI-anchored proteins instead express-ing them at a reduced level
FLAER
BFP
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Dpm2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000Dpm3
minus40 minus20 0 20 40
0
200
400
600
800
Gpaa1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Mpdu1
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pgap2
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Piga
minus40 minus20 0 20 40
0
100
200
300
400
500
600
Pigb
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
Pigc
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigf
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Pigg
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigh
minus40 minus20 0 20 40
0
5000
10000
15000
Pigk
minus40 minus20 0 20 40
0
50
100
150
200
250
Pigl
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigm
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pign
minus40 minus20 0 20 40
0
500
1000
1500
Pigo
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigq
minus40 minus20 0 20 40
0
500
1000
1500
Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
Pigu
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigv
minus40 minus20 0 20 40
0
100
200
300
400Pigw
minus40 minus20 0 20 40
0
200
400
600
800
Pigx
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000Pigy
∆7bp
∆7bp
∆5bp
∆11bp∆4bp
∆2bp∆2bp ∆2bp
∆12bp
∆9bp
∆6bp
∆6bp∆9bp
∆8bp
∆5bp
∆11bp
∆18bp
∆11bp
∆6bp ∆6bp
∆6bp
∆6bp∆6bp
∆6bp
∆6bp∆15bp
∆15bp
∆5bp∆10bp
Supplementary Figure 11 Size distribution of indels at Site 1 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Rea
d co
unts
Indel size [bp]
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
minus40 minus20 0 20 40
0
500
1000
1500
2000
Dpm1
minus40 minus20 0 20 40
0
1000
2000
3000
4000Dpm2
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Dpm3
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
6000
Gpaa1
minus40 minus20 0 20 40
Mpdu1
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500
Pgap2
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000
12000
14000
Piga
minus40 minus20 0 20 40
0
2000
4000
6000
Pigb
minus40 minus20 0 20 40
0
1000
2000
3000
4000
Pigc
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigf
minus40 minus20 0 20 40
0
200
400
600
800
Pigg
minus40 minus20 0 20 40
0
2000
4000
6000
8000
10000Pigh
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigk
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigl
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
Pigm
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
3000
3500Pign
minus40 minus20 0 20 40
0
200
400
600
800
1000
1200
Pigo
minus40 minus20 0 20 40
0
500
1000
1500Pigp
minus40 minus20 0 20 40
0
1000
2000
3000
4000Pigq
minus40 minus20 0 20 40
0
200
400
600
800
1000Pigs
minus40 minus20 0 20 40
0
500
1000
1500
2000Pigt
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500
Pigu
minus40 minus20 0 20 40
0
500
1000
1500
2000
2500Pigv
minus40 minus20 0 20 40
0
2000
4000
6000
8000
Pigw
minus40 minus20 0 20 40
0
1000
2000
3000
4000
5000
Pigx
minus40 minus20 0 20 40
Pigy
∆7bp
∆7bp∆7bp
∆7bp
∆7bp∆17bp
∆7bp
∆4bp ∆4bp ∆2bp
∆5bp
∆5bp
∆5bp ∆6bp ∆6bp
∆5bp
∆6bp ∆6bp ∆6bp
∆14bp
∆12bp
∆13bp ∆10bp ∆10bp∆14bp
NA
NA
Supplementary Figure 12 Size distribution of indels at Site 2 of each gene Deletions with clear peaks are often associated with micro-homology These deletions are marked with their deletion sizes The sequences of these sites are summarised in Supplementary Table 4
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Figure 13 Functional analysis of the Pigh∆12 gene product hCas9-expressing ESCs were transfected with the Pigh Site 1 gRNA expression vector and FLAER-negative cells were isolated by cell sorting Subsequently these cells were individually transfected with cDNA expressing each of the 26 GPI-anchor-biosynthesis pathway genes or Pigh∆12 Two days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Note that the Pigh∆12 gene product can restore the expression of GPI-anchored proteins as efficiently as wild type Pigh
Dpm1
Pgap2
Pigg Pign
Pigt
Pigy
Dpm2
Piga
Dpm3
Pigb
Gpaa1
Pigc
Mpdu1
Pigf
Pigk Pigl Pigm
Pigo Pigp Pigq Pigs
Pigu Pigv Pigw Pigx
Pighwt Pigh∆12 Control
FLAER
BFP
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Figure 14 Reproducibility of micro-homology mediated repair Size distributions of indels at Site 1 of the indicated genes from 4 independent experiments are shown Reproducibility was observed at all sites
Experiment 1 Experiment 2 Experiment 3 Experiment 4
0
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 40
Pgap2
0
1000
2000
3000
4000
5000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
4000
0-20-40 20 400
1000
2000
3000
4000
5000
6000
0-20-40 20 40
Pigm
0
1000
2000
3000
0-20-40 20 400
1000
2000
0-20-40 20 400
1000
2000
3000
0-20-40 20 400
1000
2000
3000
0-20-40 20 40
Pigp
0-20-40 20 40 0-20-40 20 40 0-20-40 20 40 0-20-40 20 40
Pigx
0
1000
2000
0
1000
2000
0
500
1000
0
500
1000
Indel size [bp]
Rea
d co
unts
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
0
20
40
60
80
100
120
Dpm
1D
pm2
Dpm
3G
paa1
Mpd
u1P
gap2
Pig
aP
igb
Pig
cP
igf
Pig
gP
igh
Pig
kP
igl
Pig
mP
ign
Pig
oP
igp
Pig
qP
igs
Pig
tP
igu
Pig
vP
igw
Pig
xP
igy
Perc
enta
ge
Ins+Del
Ins
Del
a
b
NA
NA
Supplementary Figure 15 Mutation signatures associated with CRISPR-Cas9-induced DSBs ab Signatures at Site 1(a) and Site 2 (b) of the indicated genes Mutated sequences are clasified into three groups insertion only deletion only and insertion+deletion Data are shown as mean plusmn sd (n=2-4)
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Zfp574Wdr55Wdr36Vps72Usp39
TwistnbTsr2
Tcf15Tbl3
TardbpSrsf2Srsf1
Srfbp1Snrpb
Smad7Sf3b5Sf3b3
Sf1SbdsRrp9
Rpl26Rpf1
Rbbp4Ppp1r10
Pop5Polr2jPolr1cPolr1aPmf1
Phf5aPes1Pelp1
Nrf1Nop2
Ncoa3Nanog
Imp4Imp3
Hspa8Hinfp
Gtf3c4Gemin5
Ftsj3Exosc5Exosc3Eif4a3Eftud2
EcdE4f1Dkc1
Ddx56Ddx54
Clp1Cirh1aAlyrefRNA processing
ncRNA metabolic process p=46E-20RNA processing p=28E-19rRNA processing p=18E-18rRNA metabolic process p=21E-18ncRNA processing p=82E-17RNA splicing p=81E-05mRNA processing p=10E-04tRNA metabolic process p=15E-04mRNA metabolic process p=60E-04 RNA biosynthetic process p=20E-03transcription DNA-dependent p=27E-02
Rrm2Rrm1Rpa1Rfc5
Rbbp4Pold1PcnaOrc6
Mcm7Mcm6Mcm5Mcm3Mcm2Gins4Gins2
E4f1Dna2Cinp
Brca1DNA replicationDNA replication p=69E-13DNA-dependent DNA replication p=22E-07DNA replication initiation p=67E-04DNA unwinding during replication p=22E-02DNA duplex unwinding p=28E-02DNA geometric change p=31E-02DNA metabolic process p=31E-08
Usp39Rbbp4
Ppp1cbPdcd2lMcm7Mcm6Mcm3Mcm2Hcfc1
Gnb2l1Cinp
Chmp3Arl2
Rpl13aRpl10Pfdn2Pes1
Mrpl20Hspa9Hspa8
HscbH2minusKe2Gtpbp4
Gnl2Cct7Cct5Cct4Cct3Cct2
Tcp1Rrn3Rps5Rps3
Rps20Rplp0
Rpl8Rpl6Rpl4
Rpl36aRpl26Rpl19Rpl18
Protein synthesisribosome biogenesis p=12E-22ribonucleoprotein complex biogenesis p=14E-21translation p=10E-12translation initiation p=15E-03tRNA aminoacylation for protein translation p=28E-02amino acid activation p=28E-02tRNA aminoacylation p=28E-02protein folding p=20E-03
Nubp1NarflIscu
HscbFxnCellular respiration
metallo-sulfur cluster assembly p=67E-04iron-sulfur cluster assembly p=67E-04
Cell cyclecell cycle p=73E-05mitotic cell cycle p=85E-03cell cycle phase p=31E-02
VhlPsmc4Psmc3Mdm2
Psmc4Psmc3Pou5f1
Protein degradationprotein catabolic process p=14E-02macromolecule catabolic process p=19E-02
Blastocyst developmentblastocyst development p=49E-02
1gRNA 2 3 4 5 1 2 3 4 5ESC lib1 ESC lib2
1 2 3 4 5 1 2 3 4 5
ESC lib1 ESC lib2
Supplementary Figure 16 Gene ontology analyses of the depleted genes Genes that are depleted in the ESC libraries were used for gene ontology analysis GO terms that are overrepresented with the depleted genes and genes associated with these GO terms are shown Heatmaps show the depletion rate of each gRNA in ESC libraries 1 and 2 NA not applicable since gRNAs were not designed
1000100101010010001
NA
gRNA
Dep
letio
n ra
te re
lativ
eto
the
lent
ivira
l lib
rary
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Piga (site 3)
No gRNA
B4galt7 (Site 4)
Ext2 (Site 3)
B4galt7 (Site 3)
Ext2 (Site 2)
1700016K19Rik (Site 4)1700016K19Rik (Site 3)
Cstf3 (Site 2)Cstf3 (Site 1)
FSC
FLA
ER
Supplementary Figure 17 Flow cytometry analysis of GPI-anchored protein expression in ESCs transfected with the gRNA expression vectors targeting the candidate genes hCas9-expressing ESCs were individually transfected with the vectors expressing the indicated gRNAs Six days post transfection the cells were stained with FLAER and anlaysed by flow cytometry Inactivation of these 4 candidate genes increased resistance to alpha-toxin (Fig 5c) Inactivation of the genes however did not affect GPI-anchored protein expression
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Letmd1
GM15293
GM15293 Prkg1
Mlh1 Wt
6TG-treated(2 microM)
Non-treated
Supplementary Figure 18 Validation of the candidate genes Methylene blue staining of ESCs Cas9-expressing ESCs were transfected with vectors expressing gRNAs targeting the indicated genes These cells were subsequently treated with 6TG The treatment was performed in 12-well plates Different gRNAs were used in each well and these are marked accordingly on the right panel The gRNAs targeting Mlh1 were used as a positive control in each treatment
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
TRC
N00
0030
2844
TRC
N00
0030
4996
TRC
N00
0030
5029
TRC
N00
0033
7644
TRC
N00
0033
7646
TRC
N00
0033
7713
TRC
N00
0033
7714
gRN
A si
te 1
gRN
A si
te 1
gRN
A si
te 2
Piga Pigx
alpha-toxin-treated
Non-treated
Em
pty
viru
s
Moc
k-in
fect
ed
a
b
gRN
A si
te 1
gRN
A si
te 1
Mlh1Msh6
TRC
N00
0030
3112
TRC
N00
0004
2721
gRN
A si
te 1
Pms2
TRC
N00
0024
0634
TRC
N00
0024
0635
Msh2
gRN
A si
te 1
TRC
N00
0004
2494
Em
pty
viru
s
Moc
k-in
fect
ed
6TG-treated
Non-treated
Supplementary Figure 19 Comparison between gRNA-mediated knockout and shRNA-mediated knock-down a-b Methylene blue staining of ESCs Cas9-expressing ESCs were infected with lentiviruses expressing the indicated gRNA or shRNA and treated with 10 nM alpha-toxin (a) or 2 microM 6TG (b) Alpha-toxin treatment was performed in 96-well plates 6TG treatment was performed in 12-well plates Except one shRNA target-ing Mlh1 all shRNAs were not able to produce resistant cells at a level comparable to the corresponding gRNAs
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Table 3 List of the most frequent deletion with a micro-homology
Gene Site Guide sequence PAM 3 flanking Deletion size [bp]
Dpm1 Site 1 GATGATCACATAGTTCC|CCG TGG CGTGTTT Δ7
Dpm2 Site 1 GGAGGAGGACGGCGTAG|GCG CGG GGCAGGA Δ6
Dpm3 Site 1 GCCTACCTGTTGGTCTC|CGC TGG CTGCTAT Δ10
Gpaa1 Site 1 GTCCCTCCACTGTCACA|TCG AGG CTGGTGA Δ5
Mpdu1 Site 1 GATGCTGTAGACCACGG|TTC CGG TCAGTGC Δ6
Pgap2 Site 1 GCCGGACTAGGGTCCCA|TCC CGG TCCAATG Δ11
Piga Site 1 TCACTCCAGACCCATTT|AGG AGG CATGATA Δ11
Pigb Site 1 GTAAATACTGGCGAAGA|TGA GGG GGTAAGT No strong signal
Pigc Site 1 GTTTTATTCGATCTTAT|CGA TGG AGGTGAT Δ9
Pigf Site 1 CTCAGCCATGCTTTGAG|GTT TGG TCCTAAC Δ7
Pigg Site 1 GATTTTGTGTTTGGGTC|GAA AGG TGTGAAG Δ8
Pigh Site 1 GGCCGCCAGCCACACCG|CGC AGG TGACCGC Δ2
Pigk Site 1 GTATGGAGACGATGTGG|AAG TGG ACTACAG Δ6
Pigl Site 1 TCTGCAAAGCTGTGCTG|TGT TGG GGATTCC Δ5
Pigm Site 1 GTCTACCTCAGCGAACT|CTT CGG CAAGTTT Δ2
Pign Site 1 GAGCAGGTAGGTGGACA|TCA AGG AGAGGAG Δ9
Pigo Site 1 GTGCTGATCGCTCACTT|CCT GGG TGTGGAT Δ4
Pigp Site 1 GAATTCTCTTGTGCAGA|TAC TGG GCGGTTG Δ11
Pigq Site 1 GTCAGCTAGGCCTCCGG|TGC TGG CTGTGGT Δ6
Pigs Site 1 GATCTCTCGCTCATGCA|CAA CGG TGAAAGG Δ2
Pigt Site 1 GCTTTTGGAGGACGCGA|TAC TGG GGGCCAC Δ15
Pigu Site 1 GAGGGTGTTGTTGATGG|CGC AGG TAGACTT Δ6
Pigv Site 1 GCTGATCCGCAGAGCCC|GAG GGG GCGAGGC Δ6
Pigw Site 1 GGCTATTGCCATTTTGG|CCG TGG ATTTCCC Δ6
Pigx Site 1 CGTAGTGAAGCCAACTC|ATA GGG ATCCACA Δ15
Pigy Site 1 GCGCACTGTCTGCAGTC|GCC GGG AGGTTTC Δ6
Dpm1 Site 2 GCTTTTTCTCTCGTGGT|CTT AGG AGCTTCA Δ7
Dpm2 Site 2 ACAGACCAAGCAGTAGG|ATT TGG CCTTGTC Δ6
Dpm3 Site 2 GACCATGGGAGCACTGG|GCT TGG AGTTGCC Δ6
Gpaa1 Site 2 GCCCCAGGCTCCCAAGC|GGG TGG TCCCACC Δ14
Mpdu1 Site 2 GGAAGCAGATGGCAACG|GTC TGG AGTGTCA NA
Pgap2 Site 2 GAAACGCCACACGTAGC|GTT GGG GGACCTC Δ5
Piga Site 2 GAAGAGAGCATCATGGG|CCA TGG CAGAGAA Δ7
Pigb Site 2 GTTAAGTATTCGCAGAG|CGA TGG TAAACAA Δ4
Pigc Site 2 GTCACTCCACGCCTTCA|TTA TGG TGACGTT Δ4
Pigf Site 2 ATAGAACAAAAATGATG|TGA AGG AGAAAAC Δ2
Pigg Site 2 GGGCCCAACAGCCCCCT|GAT TGG TCACAAG No strong signal
Pigh Site 2 GCCTAAGATGGTGATGA|AGA TGG TGGCAGA Δ12
Pigk Site 2 GAAAGAAGACGCTTTGA|GCG AGG GGTACTG Δ7
Pigl Site 2 GTGTAATGATTATTGAC|AAG AGG TAATTTG Δ5
Pigm Site 2 GGTAGGTCGCCCGCAGG|TAC GGG GAGCGCC Δ5
Pign Site 2 GAGGAAAGGGGACTCCA|ATA AGG GATGCCA Δ13
Pigo Site 2 GACCACCATGCAGCGTC|TAA AGG CTCTCAC Δ10
Pigp Site 2 GGGCTTTCGTTCCCGAA|TCT TGG TTAAACT Δ7
Pigq Site 2 GACTGGAGGCGGATGCA|ACC AGG AGAGCAG Δ17
Pigs Site 2 GAAGGCCTACCGGAGAG|CTT TGG AGCACGA Δ10
Pigt Site 2 GAGGCAGCACAGCGTAG|CGC AGG AAGTAGT Δ5
PigU Site 2 AGGGATGTAGCGCATTT|CCA TGG GGGTTCG Δ6
Pigv Site 2 GCAGTGCTGCAGCGTGG|ACC AGG TACACAA Δ6
Pigw Site 2 GCTGTTAATGACCCGGT|AAC AGG TGATTGC Δ7
Pigx Site 2 GGATCCACAAAGAGTCC|TGG TGG AATGTAA No strong signal
Pigy Site 2 ACCAGGAACTGCAGCAG|CGC CGG GTGGAAG NA
Predicted cut sites are shown as |
Deleted sequences are shown in bold letters
Micro-homologies at either side of the breaks are underlined
Sequence
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Table 4 Accuracy of guide RNA sequences in the whole-genome lentiviral library
Clones with correct sequences
Clones with incorrect sequences
Point mutation(s) 5 (36 )
Indel(s) 6 (43 )
Mutations in the 3 flanking region 7 (50 )
Total clones analyzed
121 (871 )
18 (129 )
139
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Table 5 GO analyses of the genes depleted in the genome-wide ESC mutant libraries
GO ID Term Count Fold enrichment Benjamini p value
GO0042254 ribosome biogenesis 29 155 123E-22
GO0022613 ribonucleoprotein complex biogenesis 30 1311 139E-21
GO0034660 ncRNA metabolic process 33 978 457E-20
GO0006396 RNA processing 44 603 275E-19
GO0006364 rRNA processing 22 178 181E-18
GO0016072 rRNA metabolic process 22 1756 207E-18
GO0034470 ncRNA processing 27 1023 824E-17
GO0006260 DNA replication 23 906 691E-13
GO0006412 translation 31 582 101E-12
GO0006259 DNA metabolic process 29 412 307E-08
GO0006261 DNA-dependent DNA replication 10 1761 218E-07
GO0007049 cell cycle 29 284 729E-05
GO0008380 RNA splicing 16 476 809E-05
GO0006397 mRNA processing 18 411 103E-04
GO0006399 tRNA metabolic process 12 636 146E-04
GO0016071 mRNA metabolic process 18 357 600E-04
GO0006270 DNA replication initiation 5 2993 672E-04
GO0031163 metallo-sulfur cluster assembly 5 2993 672E-04
GO0016226 iron-sulfur cluster assembly 5 2993 672E-04
GO0006413 translational initiation 7 1103 154E-03
GO0032774 RNA biosynthetic process 11 523 197E-03
GO0006457 protein folding 11 518 201E-03
GO0000278 mitotic cell cycle 14 343 846E-03
GO0030163 protein catabolic process 22 237 142E-02
GO0009057 macromolecule catabolic process 24 22 195E-02
GO0006268 DNA unwinding during replication 4 2177 221E-02
GO0032508 DNA duplex unwinding 4 1995 279E-02
GO0022402 cell cycle process 17 259 270E-02
GO0006418 tRNA aminoacylation for protein translation 6 781 277E-02
GO0043038 amino acid activation 6 781 277E-02
GO0043039 tRNA aminoacylation 6 781 277E-02
GO0006351 transcription DNA-dependent 9 442 273E-02
GO0032392 DNA geometric change 4 1842 308E-02
GO0022403 cell cycle phase 15 274 311E-02
GO0001824 blastocyst development 6 665 494E-02
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Table 6 A summary of gRNA hits in genome-wide screens
GPI screen MMR screen
1 627 264
2 13 7
3 3 0
4 3 0
5 0 0
6 5 1
7 3 1
8 0 3
9 0 0
10 0 0
Total 654 276
Total numbers of gRNA hits from
both ESC libraries
Number of genes with the indicated number of gRNA hits
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800
Supplementary Table 7 Primer sequences (5 gt 3)
Construction of pEF1a-hCas9
bpA-AgeI-BstZ17I U GATCACCGGTATCGATGTGCGGCCGCCGATGATCTAGAGCTCGCTGATCA
L CAGTGTATACTGCAGGTTCTTTCCGCCTCAGAAG
Construction of pPB-LR51-EF1a-puro2ACas9
pBS-MluI-XbaI U GCTCTAGACAATTCGCCCTATAGTGAGTCGT
L CGACGCGTGCTTTTGTTCCCTTTAGTGAGGG
bpA-ClaI-XhoI U CCATCGATTTAATTAACTGTGCCTTCTAGTTGCCAGCCAT
L CCGCTCGAGCCATAGAGCCCACCGCATCCCCAG
Puro-T2A-GFP U1 GATCCAATTGGGCGCGCCCCACCATGACCGAGTACAAGCCCACGGTG
L1 TCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCATGCA
U2 AGTCTTCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCACTCGAGGAATTCGGATCCATGGTGAGCAAGGGCGAGGAGCTG
L2 AGCCTTAATTAAGCGGCCGCTCACTTGTACAGCTCGTCCATGCCGAG
EF1a U GATCGCTAGCACGCGTGAGGGGCGCGGAAGCCGGGGCGGAG
L GATCCCATGGTGGTCGACCAAGCTTCCACGACACCTGAAATGGAAGAAAAAAAC
GFP U GATCAAGCTTGGCGCGCCATGGTGAGCAAGGGCGAGGA
L TACGGGATCCTTACTTGTACAGCTCGTCCA
Construction of pKLV-U6gRNA(BbsI)-PGKpuro2AGFP
pBS-MCS-KLV U GATCGGTACCTAGCGGCCGCTGGATCCGGCGCGCCCTCGAGTAACGCGTAGGGCCCATGACTAGTCAATTCGCCCTATAGTGAGTCGT
L GATCCGGCCGTTAATTAAGCTTTTGTTCCCTTTAGTGAGGG
PGKpuro2A U GATCGGATCCAATTCTACCGGGTAGGGGAG
L GCATGTTAGGAGACTTCCTCTGCCCTCTCCTCCGGACCCGCCGCCGGCACCGGGCTTGCGGGTCAT
2ABFP U1 GAGGAAGTCTCCTAACATGCGGTGACGTGGAGGAGAATCCTGGCCCAATGAGCGAGCTGATTAAGGAGA
L1 ACATGCGGCCGCTCAATTAAGCTTGTGCCCCAG
U2 CACCACATACGAGGACGGGGGCGTGCTGAC
L2 GTCAGCACGCCCCCGTCCTCGTATGTGGTG
Mouse whole genome gRNA library construction
79mer U1 GCAGATGGCTCTTTGTCCTA
L1 GCGACGAGAAGACTGTAAAAC
PCR amplification of gRNAs from libraries or enriched mutants for NextGen sequencing
gLibrary-MiSeq_150bp-PE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGAAAGTATTTCGATTTCTTGG
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTACTCGGTGCCACTTTTTCAA
gLibrary-HiSeq_50bp-SE U1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTCTTGTGGAAAGGACGAAACA
L1 TCGGCATTCCTGCTGAACCGCTCTTCCGATCTCTAAAGCGCATGCTCCAGAC
cDNA cloning
B4galt7 U1 GATCGTCGACCACCATGTTGCCCTCCCGGAGGAAAGCG
L1 GATCTGTACATCAGCCAAATATGCACCATGGGGTG
Ext2 U1 GATCGTCGACCACCATGTGTGCGTCAGTCAAGTCCAA
L1 GATCGAATTCTCATAAGCTGCCAATGTTGGGGAA
PighD12 and Pighwt U1 TCGTGGGAAGCTTGGTCGACCACCATGGAGGACGAGA
U2 CACCATCTTAGGCCTGCTTGGTTACC
L1 CAGGCCTAAGATGGTGGCAGAGAGGAC
L2 GGAATTGGATCCACAGAATTCATAAGCTTGTTGCTGTG
Nature Biotechnology doi101038nbt2800